当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析

三诺生物

(300298)

  

流通市值:76.38亿  总市值:94.91亿
流通股本:4.51亿   总股本:5.60亿

三诺生物(300298)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.03亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益342039.99万元,未分配利润116870.44万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产579110.55万元,负债237070.56万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,239,411,700.814,659,335,913.53,453,271,477.262,263,667,609.81
营业总成本1,113,224,377.194,459,321,309.323,338,133,962.972,116,582,036
其他经营收益
营业利润117,627,614.1264,007,025.33176,616,106.29192,413,943.37
利润总额120,396,466.9274,054,037.07190,767,223.84206,875,786.5
净利润102,991,394.2422,076,674.05152,743,949.16182,071,127.84
每股收益
其他综合收益-27,511,297.91-34,957,876.86-4,351,539.613,304,077.19
综合收益总额75,480,096.33-12,881,202.81148,392,409.56195,375,205.03
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,318,528,724.852,464,758,623.412,582,645,054.192,357,921,451.12
非流动资产:
非流动资产合计3,472,576,806.283,497,462,779.883,665,802,537.873,667,414,832.73
资产总计5,791,105,531.135,962,221,403.296,248,447,592.066,025,336,283.85
流动负债:
流动负债合计1,940,465,299.392,156,090,897.31,812,316,552.131,548,464,272.33
非流动负债:
非流动负债合计430,240,300.11361,948,647.01761,521,326.37710,396,955.25
负债合计2,370,705,599.52,518,039,544.312,573,837,878.52,258,861,227.58
所有者权益(或股东权益):
归属于母公司股东权益合计3,100,445,059.283,112,857,330.783,319,385,541.983,344,792,032.27
股东权益合计3,420,399,931.633,444,181,858.983,674,609,713.563,766,475,056.27
负债和股东权益合计5,791,105,531.135,962,221,403.296,248,447,592.066,025,336,283.85
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,224,277,699.865,074,328,015.473,718,770,391.372,378,494,643.81
经营活动现金流出小计1,178,383,409.514,469,183,446.893,181,541,417.712,105,129,812.18
经营活动产生的现金流量净额45,894,290.35605,144,568.58537,228,973.66273,364,831.63
投资活动产生的现金流量:
投资活动现金流入小计105,968,968.081,277,411,736.06964,855,988.98570,807,235.26
投资活动现金流出小计92,062,587.661,571,303,489.721,238,574,006.53621,481,224.74
投资活动产生的现金流量净额13,906,380.42-293,891,753.66-273,718,017.55-50,673,989.48
筹资活动产生的现金流量:
筹资活动现金流入小计81,002,288.92422,830,193.58288,150,542.75149,435,572.65
筹资活动现金流出小计216,497,009.78798,540,894.65558,186,348.08463,916,611.43
筹资活动产生的现金流量净额-135,494,720.86-375,710,701.07-270,035,805.33-314,481,038.78
汇率变动对现金及现金等价物的影响-8,270,355.53-7,126,733.52-1,918,721.911,870,204.87
现金及现金等价物净增加额-83,964,405.62-71,584,619.67-8,443,571.13-89,919,991.76
期末现金及现金等价物余额686,905,866.93770,870,272.55834,011,321.09752,534,900.46
补充资料:
现金及现金等价物的净增加额--71,584,619.67--89,919,991.76
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券宋硕,陈竹,沈睦钧0.700.830.962026-05-08
中金公司张琎,刘雅馨,朱言音0.630.75--2026-04-30
中国银河孟熙,程培0.810.981.192026-04-30
开源证券余汝意0.670.840.942026-04-29
华泰证券代雯,高鹏,杨昌源0.690.830.952026-04-28
TOP↑